abstract |
The present invention comprises administering a cyclosporin A or cyclosporin A derivative to a conjugate of a water soluble polymer and an interferon in an amount effective to alleviate or eliminate one or more of the signs or symptoms of HCV, and administering to the patient with HCV infection. A method of treating infected patients.n n n HCV, conjugate of water soluble polymer and interferon, PEGylated interferon, cyclosporin A, ribavirin. |